75MO Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3+ tumors: Focus on Asian pts
| Autor: | Kuboki, Y., Gambardella, V., Capdevila Castillon, J., Alese, O.B., Morgensztern, D., Sayehli, C.M., Sanmamed, M.F., Arriola, E., Wolf, J., Owonikoko, T.K., Studeny, M., Bouzaggou, M., Song, E., Wermke, M. |
|---|---|
| Zdroj: | In Annals of Oncology November 2023 34 Supplement 4:S1495-S1495 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|